Publication:
Current opinions in Kawasaki disease

dc.contributor.authorsBarlan I.B., Sevinc A., Bakir M.
dc.date.accessioned2022-03-28T14:50:09Z
dc.date.accessioned2026-01-11T14:28:57Z
dc.date.available2022-03-28T14:50:09Z
dc.date.issued1996
dc.description.abstractOne of the common childhood vasculitis, Kawasaki Disease, (KD) is characterized by persistent fever, bilateral conjunctival injection, oropharyngeal mucous membrane changes, erythema and/or edema of hands, polymorphous rash, and cervical lymphadenopathy. Recovery is generally complete in patients who do not have detectable coronary vasculitis. Aspirin is the mainstay of treatment and is used to prevent thrombus formation and ischemic heart disease. Intravenous gamma globulin reduces the fever and systemic manifestations of the disease and decreases the incidence of coronary artery aneurysms.
dc.identifier.issn10191941
dc.identifier.urihttps://hdl.handle.net/11424/255336
dc.language.isoeng
dc.relation.ispartofMarmara Medical Journal
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleCurrent opinions in Kawasaki disease
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage152
oaire.citation.issue3
oaire.citation.startPage148
oaire.citation.titleMarmara Medical Journal
oaire.citation.volume9

Files